BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33681683)

  • 1. Predictors of Outcomes of Patients Referred to a Transplant Center for Urgent Liver Transplantation Evaluation.
    Alshuwaykh O; Kwong A; Goel A; Cheung A; Dhanasekaran R; Ahmed A; Daugherty T; Dronamraju D; Kumari R; Kim WR; Nguyen MH; Esquivel CO; Concepcion W; Melcher M; Bonham A; Pham T; Gallo A; Kwo PY
    Hepatol Commun; 2021 Mar; 5(3):516-525. PubMed ID: 33681683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics of human immunodeficiency virus patients being referred for liver transplant evaluation: a descriptive cohort study.
    Martel-Laferrière V; Michel A; Schaefer S; Bindal S; Bichoupan K; Branch AD; Huprikar S; Schiano TD; Perumalswami PV
    Transpl Infect Dis; 2015 Aug; 17(4):527-35. PubMed ID: 25929731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors Associated With Liver Transplant Referral Among Patients With Cirrhosis at Multiple Safety-Net Hospitals.
    Yilma M; Kim NJ; Shui AM; Tana M; Landis C; Chen A; Bangaru S; Mehta N; Zhou K
    JAMA Netw Open; 2023 Jun; 6(6):e2317549. PubMed ID: 37289453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validating a novel score based on interaction between ACLF grade and MELD score to predict waitlist mortality.
    Abdallah MA; Kuo YF; Asrani S; Wong RJ; Ahmed A; Kwo P; Terrault N; Kamath PS; Jalan R; Singal AK
    J Hepatol; 2021 Jun; 74(6):1355-1361. PubMed ID: 33326814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the clinical course of acute-on-chronic liver failure prior to liver transplantation on post-transplant survival.
    Sundaram V; Kogachi S; Wong RJ; Karvellas CJ; Fortune BE; Mahmud N; Levitsky J; Rahimi RS; Jalan R
    J Hepatol; 2020 Mar; 72(3):481-488. PubMed ID: 31669304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model for end-stage liver disease-sodium underestimates 90-day mortality risk in patients with acute-on-chronic liver failure.
    Hernaez R; Liu Y; Kramer JR; Rana A; El-Serag HB; Kanwal F
    J Hepatol; 2020 Dec; 73(6):1425-1433. PubMed ID: 32531416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.
    Yamashiki N; Sugawara Y; Tamura S; Kaneko J; Nojiri K; Aoki T; Sakamoto Y; Hasegawa K; Koike K; Kokudo N
    Transplant Proc; 2012 Mar; 44(2):389-92. PubMed ID: 22410024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: Results of the ELITA/EF-CLIF collaborative study (ECLIS).
    Belli LS; Duvoux C; Artzner T; Bernal W; Conti S; Cortesi PA; Sacleux SC; Pageaux GP; Radenne S; Trebicka J; Fernandez J; Perricone G; Piano S; Nadalin S; Morelli MC; Martini S; Polak WG; Zieniewicz K; Toso C; Berenguer M; Iegri C; Invernizzi F; Volpes R; Karam V; Adam R; Faitot F; Rabinovich L; Saliba F; Meunier L; Lesurtel M; Uschner FE; Fondevila C; Michard B; Coilly A; Meszaros M; Poinsot D; Schnitzbauer A; De Carlis LG; Fumagalli R; Angeli P; Arroyo V; Jalan R;
    J Hepatol; 2021 Sep; 75(3):610-622. PubMed ID: 33951535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystatin C and Sarcopenia Predict Acute on Chronic Liver Failure Development and Mortality in Patients on the Liver Transplant Waiting List.
    Mauro E; Crespo G; Martinez-Garmendia A; Gutierrez-Acevedo MN; Diaz JM; Saidman J; Bermudez C; Ortiz-Patron J; Garcia-Olveira L; Zalazar F; Narvaez A; Spina JC; Orta R; Savluk L; Piano S; Marciano S; Gadano A
    Transplantation; 2020 Jul; 104(7):e188-e198. PubMed ID: 32150034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes After Listing for Liver Transplant in Patients With Acute-on-Chronic Liver Failure: The Multicenter North American Consortium for the Study of End-Stage Liver Disease Experience.
    O'Leary JG; Bajaj JS; Tandon P; Biggins SW; Wong F; Kamath PS; Garcia-Tsao G; Maliakkal B; Lai J; Fallon M; Vargas HE; Thuluvath P; Subramanian R; Thacker LR; Reddy KR
    Liver Transpl; 2019 Apr; 25(4):571-579. PubMed ID: 30724010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
    Kwong AJ; Lai JC; Dodge JL; Roberts JP
    Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors Associated With Access to and Receipt of Liver Transplantation in Veterans With End-stage Liver Disease.
    Kanwal F; Hernaez R; Liu Y; Taylor TJ; Rana A; Kramer JR; Naik AD; Smith D; Taddei T; Asch SM
    JAMA Intern Med; 2021 Jul; 181(7):949-959. PubMed ID: 34028505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic encephalopathy is associated with significantly increased mortality among patients awaiting liver transplantation.
    Wong RJ; Gish RG; Ahmed A
    Liver Transpl; 2014 Dec; 20(12):1454-61. PubMed ID: 25155379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum sodium and survival benefit of liver transplantation.
    Sharma P; Schaubel DE; Goodrich NP; Merion RM
    Liver Transpl; 2015 Mar; 21(3):308-13. PubMed ID: 25504743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of a Prohibitive Versus Restrictive Tobacco Policy on Liver Transplant Candidate Outcomes.
    Likhitsup A; Hassan A; Mellinger J; Askari F; Winder GS; Saeed N; Sonnenday CJ; Sharma P; Fontana RJ
    Liver Transpl; 2019 Aug; 25(8):1165-1176. PubMed ID: 31116906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of State Medicaid Expansion With Racial/Ethnic Disparities in Liver Transplant Wait-listing in the United States.
    Nephew LD; Mosesso K; Desai A; Ghabril M; Orman ES; Patidar KR; Kubal C; Noureddin M; Chalasani N
    JAMA Netw Open; 2020 Oct; 3(10):e2019869. PubMed ID: 33030554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma.
    Young K; Aguilar M; Gish R; Younossi Z; Saab S; Bhuket T; Liu B; Ahmed A; Wong RJ
    Liver Transpl; 2016 Oct; 22(10):1356-66. PubMed ID: 27348270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors and outcome of emergent Liver transplantation for patients with acute-on-chronic liver failure.
    Kim JE; Sinn DH; Choi GS; Kim JM; Joh JW; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
    Dig Liver Dis; 2021 Aug; 53(8):1004-1010. PubMed ID: 33931340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High risk of delisting or death in liver transplant candidates following infections: Results from the North American Consortium for the Study of End-Stage Liver Disease.
    Reddy KR; O'Leary JG; Kamath PS; Fallon MB; Biggins SW; Wong F; Patton HM; Garcia-Tsao G; Subramanian RM; Thacker LR; Bajaj JS;
    Liver Transpl; 2015 Jul; 21(7):881-8. PubMed ID: 25845966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Black Patients Have Unequal Access to Listing for Liver Transplantation in the United States.
    Rosenblatt R; Wahid N; Halazun KJ; Kaplan A; Jesudian A; Lucero C; Lee J; Dove L; Fox A; Verna E; Samstein B; Fortune BE; Brown RS
    Hepatology; 2021 Sep; 74(3):1523-1532. PubMed ID: 33779992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.